Advertisement
Advertisement

China’s changing health system

There are many challenges China’s health care system is facing during the pandemic, but drug developers and tech firms are among the forces fighting the country’s worst public health crisis in two decades.

Updated: 08 Sep, 2020
Advertisement
[1]

What did China’s health care learn from the Sars and Covid-19 outbreaks?

In the first of a five-part series on China’s healthcare system, Peggy Sito outlines the challenges facing the system worth US$2.3 trillion by 2030 in the most populous nation, as it finds itself at the epicentre of a second coronavirus outbreak in two decades.

14 Mar, 2020
China’s public-sector expenditure on health care increased almost 14-fold between the Sars outbreak in 2003 and the end of 2018. Illustration: SCMP
Advertisement
Advertisement
[2]

China’s Big Tech use coronavirus record to turbocharge HealthTech

In the second of a five-part series on China’s health care system, Eric Ng looks at how technological innovations – smartphone applications, 5G, big data, artificial intelligence – are coming together to help in the battle with the country’s worst public health crisis in two decades.

21 Mar, 2020
Illustration: Henry Wong
[3]

Chinese biotechs join the worldwide race to find a coronavirus cure

In the third of a five-part series on China’s health care system, Eric Ng looks at how a new breed of Chinese drug developers, armed with innovative treatments ranging from cancer to Alzheimer’s, has taken the lead to find a cure for the coronavirus pandemic ravaging the world.

28 Mar, 2020
Illustration: Brian Wang
[4]

Here’s how tech cuts China’s medical cost to the price of a Starbucks coffee

In the fourth in a five-part series, Enoch Yiu looks how technology firms like Ant Financial and Tencent Holdings are using their innovative powers to create insurtech and mutual aid platforms that make health care coverage affordable to more people.

04 Apr, 2020
 
[5]

How Wuhan and the coronavirus are shaping China’s medical reforms

In the last of a five-part series, Peggy Sito considers the impact Beijing’s intervention against Covid-19 – in Wuhan and elsewhere – will have on its health care policies in the longer term.

11 Apr, 2020
Illustrator: Brian Wang